Zofran Lawsuit Alleges Drugmaker Knew About Risks

April 2, 2015

Zofran lawsuits alleging the maker of the prescription drug knew about the risks of Zofran side effects but did not warn patients have now been filed against GlaxoSmithKline (GSK). The lawsuits claim GSK knew about Zofran risks to unborn fetuses but failed to adequately warn expectant mothers who were given the drug to treat nausea associated with pregnancy.

According to court documents filed in one lawsuit, Zofran was designed to treat patients who had severe nausea typically associated with cancer treatments such as chemotherapy or radiation. But the lawsuit (Flynn v. GlaxoSmithKline, case number 2:15-cv-00709-PD; filed 2/12/15) alleges GSK not only marketed Zofran “off-label” as a safe and effective treatment for pregnancy-related nausea and vomiting, it did so without even having tested the drug for its potential risks to pregnant mothers and their unborn babies.

“Unlike another anti-nausea prescription drug available on the market - which is FDA-approved in the United States for treating morning sickness in pregnant women - GSK never conducted a single clinical trial before marketing Zofran to pregnant women,” the lawsuit alleges. “GSK simply chose not to study Zofran in pregnant women or seek FDA approval to market the drug for treatment during pregnancy.”

It is not illegal for doctors to prescribe drugs off-label, but it is illegal for drug manufacturers to market their drugs for unapproved uses.
 

 

Flynn’s lawsuit alleges GSK chose not to conduct studies because it would have hurt profits. As a result, Flynn claims, women took drugs while pregnant that they thought were safe but in fact were not. GSK allegedly knew the drugs were unsafe because of animal studies that showed evidence of intrauterine deaths and malformations in the offspring, proof that Zofran could cross the placental barrier and affect fetuses, according to the lawsuit.

In addition to the animal studies, the lawsuit claims that by 2000, GSK knew of 32 reports of birth defects linked to Zofran and now has more than 200 reports. But, GSK has allegedly not warned women about the risks of taking Zofran while pregnant.

Flynn alleges that two of her children were born with birth defects after being exposed to Zofran. Her first child, born in 2004, had a congenital heart defect, has undergone surgery to repair the hole and has not thrived physically or developmentally. Flynn’s second child was born in 2006 also with a congenital heart defect and required 24-hour monitoring of her oxygen levels. Flynn argues that if she had known about the risks of Zofran she would not have taken it while pregnant.

 

Please reload

Featured Posts

Boston, MA: Two product liability lawsuits have now been filed against GlaxoSmithKline (GSK), the maker of Zofran, claiming the drug used during pregn...

Zofran Birth Defects Lawsuits: Just the Cost of Doing Business for GlaxoSmithKline?

April 8, 2015

1/3
Please reload

Recent Posts
Please reload

Archive
Please reload

.

The Law Offices of A. Craig Eiland, PC

 

866.529.8900

 

2211 The Strand, Suite 201, Galveston, TX 77550 ■ (p) 409.763.3260 ■  (f) 409.763.8154

 

1220 Colorado Street, Suite 300, Austin, TX 78701 ■ (p) 512.482.3260 ■ (f) 512.482.3261 

 

 

 

Craig Eiland, Million Dollar Advocates

Forum, LLC

Craig Eiland, Best Lawyers/Best Law Firms by Woodward/White, Inc

Disclaimer

The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for advice regarding your individual situation. We invite you to contact us and welcome your calls, letters and electronic mail. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.

©  2018 by The Law Offices of Craig Eiland